Website profile

Biospace

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V

  • 344articles · 30d
  • 5+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 92%with images
  • 291avg words
articles per day
Categories
  • Economy, Business & Finance 196
  • Health & Wellness 161
  • Medical 159
  • Business & Industrial 143
  • Finance & Business 132
  • Health 75
  • Science & Technology 55
  • Science & Nature 36

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioSpace
biospace.com > press-releases > neurelis-ceo-craig-chambliss-to-present-keynote-at-the-14th-annual-outsourcing-in-clinical-trials-southern-california-2026-conference

NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE

3+ day, 8+ hour ago   (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...

BioSpace
biospace.com > press-releases > tenpoint-therapeutics-to-participate-in-upcoming-investor-conferences-and-medical-meetings

Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings

4+ day, 20+ hour ago   (200+ words) BioSpace Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings LONDON & WARREN, N.J.--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced participation…...

BioSpace
biospace.com > press-releases > viridian-therapeutics-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference

Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference

1+ week, 4+ day ago   (248+ words) BioSpace Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced…...

BioSpace
biospace.com > press-releases > calluna-pharma-announces-participation-in-upcoming-scientific-and-investor-conferences

Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences

1+ week, 5+ day ago   (209+ words) Company to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout European Respiratory Society (ERS) Congress 2026 Barcelona, Spain Sept. 5–9, 2026 Jonas Hallen, M.D., Ph.D. (CMO) and Toby Maher, M.D., Ph.D. (Coordinating Investigator on the AURORA study) will…...

Google News
biospace.com > press-releases > glaukos-announces-participation-in-wells-fargo-healthcare-conference

Glaukos Announces Participation in Wells Fargo Healthcare Conference

3+ week, 5+ day ago   (214+ words) BioSpace Glaukos Announces Participation in Wells Fargo Healthcare Conference ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today…...